In short, our findings illustrate that WBP2 modulates the expression and activity of ENO1 and further mediates EMP pathway activity through the PI3K/Akt signaling pathway, to regulate the biologic behavior of glioma cells. This evidence concerns the gene ENO1 and central nervous system cancer.